Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
The future of retatrutide research Retatrutide is still in active clinical development by Eli Lilly under multiple Phase 3 trial programs
Our streamlined process ensures a hassle-free experience, allowing you to quickly and conveniently request the medication you need from home
The SURMOUNT-5 clinical trial published in The New England Journal of Medicine showed that Zepbound (tirzepatide) achieved an average weight loss of 20.2% compared to 13.7% with Wegovy (semaglutide) at 72 weeks
GLP-1 Weight Loss Specialist in Langhorne and Philadelphia, PA GLP-1 medications offer an effective solution for weight management by helping regulate appetite, improve metabolism, and support long-term weight loss
US$ 29.29
US$ 28.32
US$ 29.58
